Grant of Options

Synexus Clinical Research PLC
20 February 2007


SYNEXUS CLINICAL RESEARCH PLC (the "Company")

GRANT OF OPTIONS

On 19 February 2007, options over 250,000 ordinary shares of 10p each in Synexus
Clinical Research PLC were granted to Alan Boyce, a director of the Company, in
accordance with the Rules of the EMI Scheme and Unapproved Share Option Scheme.
The options are exercisable in the period 19 February 2007 to 19 February 2017
at a price of 52.5p per share representing a grant value of £131,250 and are
Alan Boyce's only interest in the issued share capital of the Company.

ENDS



                      This information is provided by RNS
            The company news service from the London Stock Exchange